Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study

JAKi treatment provided sustained disease control (especially in high-risk RA patients) and promoted GC reduction. Although TNFi remains a standard option, JAKi treatment may be preferable in patients with 4PPFs. Further research should evaluate JAKi treatment's long-term safety and efficacy.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-10-17
DOI
https://doi.org/10.1093/rheumatology/keaf552
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study

Koji Kinoshita, Kohei Tsujimoto, Chisato Ashida, Sho Sendo et al.
Lara D. Veeken
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study

Koji Kinoshita, Kohei Tsujimoto, Chisato Ashida, Sho Sendo, Toshihiko Shiga, Motomu Hashimoto, Daisuke Tomita, Yuji Nozaki, Koichi Murata, Tadashi Okano, Tetsu Itami, Hideyuki Shiba, Akira Ōnishi, Yonsu Son, Yumi Morimoto, Wataru Yamamoto, Naofumi Yoshida, Rika Fukuda, H. Yamada, Y Hiramatsu, Kazuya Kishimoto
article en

Abstract

JAKi treatment provided sustained disease control (especially in high-risk RA patients) and promoted GC reduction. Although TNFi remains a standard option, JAKi treatment may be preferable in patients with 4PPFs. Further research should evaluate JAKi treatment's long-term safety and efficacy.

Lara D. VeekenVol. 65(1)
Kansai Medical University (JP), Kyoto University (JP), Kurashiki Central Hospital (JP), Kindai University Hospital (JP), Osaka Metropolitan University (JP), Kobe University (JP), Osaka University of Pharmaceutical Sciences (JP), Kindai University (JP), The University of Osaka (JP)
Openalex Percentile: Top 56%
Myeloproliferative Neoplasms: Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.